LUNG CANCER RISK ASSOCIATED WITH EXPOSURE TO MAN-MADE FIBERS

REFERENCES

• Blot W. J., Fraumeni J. F., Jr. Cancers of the lung and pleura. Cancer Epidemiology and Prevention 1996; 637–665
   Google Scholar
• Saracci R., Simonato L., Acheson E. D., Anderson A., Bertazzi P. A., et al. Mortality and incidence of cancer of workers in the man made vitreous fibres producing industry: an international investigation at 13 European plants. British Journal of Industrial Medicine 1984; 41: 425–436
   PubMedGoogle Scholar
• Gardner M. J., Winter P. D., Pannett B., Simpson M. J. C., Hamilton C., Acheson E. D. Mortality study of workers in the man-made mineral fiber production industry in the United Kingdom. Scandinavian Journal of Work, Environment and Health 1986; 12(suppl 1)85–93
   PubMedGoogle Scholar
• Miettinen O. S., Rossiter C. E. Man-made mineral fibers and lung cancer. Scandinavian Journal of Work, Environment and Health 1990; 16: 221–231
   PubMed Web of Science ®Google Scholar
• Gustavsson P., Plato N., Axelson O., Brage H. N., Hogstedt C., Ringback G., Tornling G., Wingren G. Lung cancer risk among workers exposed to man-made mineral fibers (MMMF) in the Swedish prefabricated house industry. American Journal of Industrial Medicine 1992; 21: 825–834
   PubMed Web of Science ®Google Scholar
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Man-made Mineral Fibres and Radon. IARC, LyonFrance 1988; 43
   Google Scholar
• Berman D. W., Crump K. S., Chatfield E. J., Davis J. M. G., Jones A. D. The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Analysis 1995; 15: 181–195
   PubMed Web of Science ®Google Scholar
• Everitt J. I. Mechanisms of fiber-induced diseases: implications for the safety evaluation of synthetic vitreous fibers. Regulatory Toxicology and Pharmacology 1994; 20: S68–S75
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck E. G., Turim J., Hanna L. Quantitative assessment of the risk of lung cancer associated with occupational exposure to refractory ceramic fibers. Risk Analysis, in press
   Web of Science ®Google Scholar
• Yu C. P., Zhang L., Oberdoster G., Mast R. W., Maxim L. D., Utell M. J. Deposition of refractory ceramic fibers (RCF) in the human respiratory tract and comparison with rodent studies. Aer Sci Tech 1995; 23: 291
   Web of Science ®Google Scholar
• Yu C. P., Ding Y. J., Zhang L., Oberdoster G., Mast R. W., Maxim L. D., Utell M. J. Retention modeling of refractory ceramic fibers (RCF) in humans. Regulatory Toxicology and Pharmacology 1997; 25: 18–25
   PubMed Web of Science ®Google Scholar
• Rossiter C. E., Chase J. R. Statistical analysis of results of carcinogenicity studies of synthetic vitreous fibres at Research and Consulting Company, Geneva. Annals of Occupational Hygiene 1995; 39: 759–769
   PubMed Web of Science ®Google Scholar
• Hesterberg T. W., Miller W. C., McConnell E. E., Chevalier J., Hadley J. G., Bernstein D. M., Thevenaz P., Anderson R. Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundamental and Applied Toxicology 1993; 20: 464–476
   PubMedGoogle Scholar
• Cox D. R., Oakes D. Analysis of Survival Data. Chapman and Hall, New York 1984
   Google Scholar
• Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science 1990; 249: 1007–1011
   PubMed Web of Science ®Google Scholar
• Armitage P., Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. British Journal of Cancer 1954; 8: 1–12
   PubMed Web of Science ®Google Scholar
• Knudson A. G. Mutation and cancer: Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Knudson A. G. Mutation and cancer: : A model for human carcinogenesis. Journal of the National Cancer Institute 1981; 66: 1037–1052
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck G. Two-event model for carcinogenesis: biological, mathematical and statistical considerations. Risk Analysis 1990; 10: 323–341
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Venzon D. J. Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Mathematical Biosciences 1979; 47: 55–77
   Web of Science ®Google Scholar
• Luebeck E. G., Curtis S. B., Cross F. T., Moolgavkar S. H. Two-stage model of radon-induced malignant lung tumors in rats: Effects of cell killing. Radiation Research 1996; 145: 163–173
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck E. G., Krewski D., Zielinski J. M. Radon, cigarette smoke and lung cancer: A re-analysis of the Colorado Plateau uranium miners' data. Epidemiology 1993; 4: 204–217
   PubMed Web of Science ®Google Scholar
• Kai M., Luebeck E. G., Moolgavkar S. H. Analysis of solid cancer incidence among atomic bomb survivors using a two-stage model of carcinogenesis. Radiation Research 1997; 148: 348–358
   PubMed Web of Science ®Google Scholar
• Heidenreich W. F. On the parameters of the clonal expansion model. Radiation and Environmental Biophysics 1996; 35: 127–129
   PubMed Web of Science ®Google Scholar
• Heidenreich W. F., Luebeck E. G., Moolgavkar S. H. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Analysis 1997; 17: 391–399
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck E. G. A two-mutation model for radiation carcinogenesis in humans and rodents. New Frontiers in Cancer Causation 1993; 199–210
   Google Scholar
• Peto R., Lopez A. D., Boreham J., Thun M., Heath C., Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268–1278
   PubMed Web of Science ®Google Scholar
• Creutzenberg O., Bellman B., Muhle H. Biopersistence and bronchoalveolar lavage investigations in rats after subacute inhalation of various man-made mineral fibres. Inhaled Particles VIII. Annals of Occupational Hygiene 1997; 41(suppl 1)213–218
   Google Scholar
• Morrow P. E., Haseman J. K., Hobbs C. H., Driscoll K. E., Vu V., Oberdoster G. The maximum tolerated dose for inhalation bioassays: toxicity vs overload. Fundamental and Applied Toxicology 1996; 29: 155–167
   PubMedGoogle Scholar
• Muhle H., Bellman B. Personal Communication
   Google Scholar
• Hext P. M. Current perspectives on particle induced pulmonary tumours. Human and Experimental Toxicology 1994; 13: 700–715
   PubMed Web of Science ®Google Scholar